These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37928558)

  • 1. Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.
    Cao Y; Rische CH; Bochner BS; O'Sullivan JA
    Front Immunol; 2023; 14():1283370. PubMed ID: 37928558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death
    Carroll DJ; Cao Y; Bochner BS; O'Sullivan JA
    Front Immunol; 2021; 12():737988. PubMed ID: 34721399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
    Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
    J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation.
    Kano G; Almanan M; Bochner BS; Zimmermann N
    J Allergy Clin Immunol; 2013 Aug; 132(2):437-45. PubMed ID: 23684072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
    Bochner BS
    Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
    O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
    Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases.
    Kano G; Bochner BS; Zimmermann N
    Immunobiology; 2017 Feb; 222(2):343-349. PubMed ID: 27682013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.
    Kiwamoto T; Katoh T; Evans CM; Janssen WJ; Brummet ME; Hudson SA; Zhu Z; Tiemeyer M; Bochner BS
    J Allergy Clin Immunol; 2015 May; 135(5):1329-1340.e9. PubMed ID: 25497369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways.
    Nutku-Bilir E; Hudson SA; Bochner BS
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):121-4. PubMed ID: 17690326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
    Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
    J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the endogenous sialoglycan ligand for eosinophil death receptor Siglec-8 in chronic rhinosinusitis with hyperplastic nasal polyposis.
    Lee HS; Gonzalez-Gil A; Drake V; Li TA; Schnaar RL; Kim J
    Glycobiology; 2021 Sep; 31(8):1026-1036. PubMed ID: 33755113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils.
    Na HJ; Hudson SA; Bochner BS
    Cytokine; 2012 Jan; 57(1):169-74. PubMed ID: 22079334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
    Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
    Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
    J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways.
    Gonzalez-Gil A; Porell RN; Fernandes SM; Wei Y; Yu H; Carroll DJ; McBride R; Paulson JC; Tiemeyer M; Aoki K; Bochner BS; Schnaar RL
    Glycobiology; 2018 Oct; 28(10):786-801. PubMed ID: 29924315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
    Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
    Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.